Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dysmorphophobia].

C Mehler-Wex1, A Warnke

  • 1Klinik u Poliklinik für Kinder- u Jugendpsychiatrie u Psychotherapie, Würzburg. mehler@kjp.uni-wuerzburg.de

MMW Fortschritte Der Medizin
|April 15, 2006
PubMed
Summary
This summary is machine-generated.

Body dysmorphic disorder involves excessive preoccupation with imagined bodily defects, often leading to demands for surgery. Selective serotonin reuptake inhibitors are the primary treatment, while surgery may transfer symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.

Frontiers in pharmacology·2026
Same author

Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.

European journal of clinical pharmacology·2021
Same author

Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.

European journal of clinical pharmacology·2020
Same author

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie·2015
Same author

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie·2015
Same journal

MMW Fortschritte der Medizin·2026
Same journal

[Opportunistic infection: tuberculosis].

MMW Fortschritte der Medizin·2026
Same journal

[Screening for anal intraepithelial neoplasia (AIN) and anal cancer].

MMW Fortschritte der Medizin·2026
Same journal

[Health equity under threat. What the cuts to international health aid mean].

MMW Fortschritte der Medizin·2026
Same journal

[Broadly neutralizing antibodies against HIV: Perspectives for individualized and long-acting treatment approaches.]

MMW Fortschritte der Medizin·2026
Same journal

[A cure for HIV: What are the limits?]

MMW Fortschritte der Medizin·2026
See all related articles

Area of Science:

  • Psychiatry
  • Psychology

Context:

  • Body dysmorphic disorder (BDD) is classified under somatoform disorders in ICD-10 (F45.2).
  • Characterized by excessive preoccupation with an imagined, non-objectifiable bodily defect.
  • Often affects visible body parts crucial for perceived attractiveness.

Purpose:

  • To outline the diagnostic and treatment considerations for body dysmorphic disorder.
  • To highlight the limitations of surgical interventions and the role of psychiatric referral.

Summary:

  • BDD involves intense focus on perceived flaws, frequently leading to requests for surgical correction.
  • Associated conditions include depression, social phobia, obsessive-compulsive disorder, and self-harm.
  • Onset is typically in early life, with an estimated 5% lifetime prevalence.

Related Experiment Videos

  • Serotonergic system involvement suggests selective serotonin reuptake inhibitors (SSRIs) as first-line pharmacotherapy.
  • Surgical procedures do not resolve BDD and may lead to symptom transference.

    • Impact:

    • Emphasizes the importance of accurate psychiatric diagnosis for effective BDD management.
    • Discourages surgical interventions as a primary treatment, redirecting focus to pharmacotherapy and psychotherapy.
    • Highlights the potential for co-occurring mental health conditions and the need for comprehensive care.